Lymphoproliferative Disorders clinical trials

Explore recruiting lymphoproliferative disorders clinical trials.

Recruiting lymphoproliferative disorders studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphoproliferative Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in EBV negative kidney transplant recipients on incidence of EBV primary infection and post-transplant lymphoproliferative disorders - REPLY

France

Therapeutic use (Phase IV) EU CTIS Study details

Lymphoproliferative Disorders trials by city

Lymphoproliferative Disorders clinical trials

Recruiting lymphoproliferative disorders studies right now

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)

Q702 for the Treatment of Patients With Hematologic Malignancies

Self-administration of Subcutaneous Elranatamab in the Patients' Homes.

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.

Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Also recruiting in Europe

Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in EBV negative kidney transplant recipients on incidence of EBV primary infection and post-transplant lymphoproliferative disorders - REPLY

Lymphoproliferative Disorders trials by city

Other conditions